GENERAL AIR SERVICE & SUPPLY COMPANY
PharmaGENERAL AIR SERVICE & SUPPLY COMPANY is a pharmaceutical company with 2 FDA-approved products.
GENERAL AIR SERVICE & SUPPLY COMPANY's Key Drugs
GENERAL AIR SERVICE & SUPPLY COMPANY's core commercial portfolio centers on HELIUM, USP — its most strategically important drugs approved in the last 15 years.
GENERAL AIR SERVICE & SUPPLY COMPANY's Recent FDA Approvals
GENERAL AIR SERVICE & SUPPLY COMPANY secured 1 new FDA approval for novel drugs (NDA/BLA) in the last two years.
GENERAL AIR SERVICE & SUPPLY COMPANY's Therapeutic Areas
Disease areas where GENERAL AIR SERVICE & SUPPLY COMPANY has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
GENERAL AIR SERVICE & SUPPLY COMPANY Pipeline Snapshot
Active clinical trials for GENERAL AIR SERVICE & SUPPLY COMPANY across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • HELIUM, USP leads revenue
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2021-07-26
- Latest
- 2026-02-02
- Applications
- 2